GATA3 Mouse Monoclonal Antibody [Clone ID: OTI8E11] TA809142S from OriGene Technologies | Biocompare.com

Supplier Images

GATA3 Mouse Monoclonal Antibody [Clone ID: OTI8E11]

Be the first to write a review!

Supplier Page from
OriGene Technologies for
GATA3 Mouse Monoclonal Antibody [Clone ID: OTI8E11]

OriGene Technologies' GATA3 Mouse Monoclonal Antibody [Clone ID: OTI8E11] is a Mouse monoclonal antibody. It reacts with Human, Mouse, and Rat. This antibody has been shown to work in applications such as: Flow Cytometry, Immunofluorescence, and Western Blot.

Description

GATA3 mouse monoclonal antibody, clone OTI8E11 (formerly 8E11)

Product Specs
ItemGATA3 Mouse Monoclonal Antibody [Clone ID: OTI8E11]
CompanyOriGene Technologies
Price Pricing Info Supplier Page View Company Product Page
Catalog NumberTA809142S
Quantity30 µl
Concentration1 mg/ml
ClonalityMonoclonal
IsotypeIgG2b
ReactivityHuman, Mouse, Rat
ApplicationsFC, IF, WB
HostMouse
TargetGATA3
NCBI Full Gene NameGATA binding protein 3
NCBI Gene AliasesHDR, HDRS
Conjugate/TagUnconjugated
FormatPBS (PH 7.3) containing 1% BSA, 50% glycerol and 0.02% sodium azide
TypePrimary Antibodies
PurityPurified from mouse ascites fluids or tissue culture supernatant by affinity chromatography (protein A/G)
CloneOTI8E11
ImmunogenHuman recombinant protein fragment corresponding to amino acids 155-443 of human GATA3 (NP_001002295) produced in E.coli
Antibody TypePrimary Antibodies

Add to Compare List

OriGene Technologies

OriGene Technologies

9620 Medical Center Drive # 200

Rockville, Maryland 20850

United States

Phone: 1-888-267-4436 (U.S. only) / 301-340-3188
301-340-9254

Company Profile

Website: http://www.origene.com

Be the First to Write a Review!

Webinar: Improving Cancer Biomarker Detection with Multiplex Technology
The quantification of soluble biomarkers, including chemokines and cytokines, in plasma or serum is ... Read More
Screening of Leukemic Neoantigen Specific T cells with the iQue Screener PLUS
In this webinar, Alison Tarke, a Research Scientist at PersImmune, delivers the presentation "... Read More